Abstracts Archive - Page 1869 of 2607 - ACR Meeting Abstracts

Abstract Number: 3231 • 2015 ACR/ARHP Annual Meeting
A Systematic Review of the Persuasive Design Principles Used in Health Apps for Arthritis
Jonas Geuens¹, Vero Vanden Abeele², Thijs Swinnen³, R Westhovens⁴, Kurt L. de Vlam⁴ and Luc Geurts⁵, ¹Faculty of Engineering Technology, KU Leuven, Leuven, Belgium, ²Technology Cluster Computerscience, KU Leuven, Leuven, Belgium, ³Rheumatology, UZ Leuven, Leuven, Belgium, ⁴Rheumatology, University Hospitals Leuven, Leuven, Belgium, ⁵Electrical Engineering (ESAT), KU Leuven, Leuven, Belgium
Background/Purpose: Recently, we witnessed a steep increase in the amount of mobile applications (apps) in the category of “Health & Fitness”. Most popular examples of…
Abstract Number: 3232 • 2015 ACR/ARHP Annual Meeting
The Comparative Efficacy of Kinesio Taping and Local Steroid Injection in Patients with Subacromial Impingement Syndrome
Hamit Goksu¹, Pinar Borman², Figen Gokoglu³ and Seher Kocaoglu², ¹Clinic of Physical Medicine and Rehabilitation, Ankara Training and Research Hospital, Ankara, Turkey, ²Department of 1st Physical Medicine and Rehabilitation, Ministry of Health Ankara Education and Research Hospital, Ankara, Turkey, ³Dept of Physical Medicine and Rehabilitation, Ahi Evran University, Medical Faculty, Kýrþehir, Turkey
Background/Purpose: There are several approaches in the treatment of subacromial impingement syndrome (SIS). The aim of this study was to compare the therapeutic effects of…
Abstract Number: 3233 • 2015 ACR/ARHP Annual Meeting
A Comparison of Interobserver Agreement Between Advanced Practice Physiotherapists and Rheumatologists in the Detection of Axial Spondyloarthritis
Laura Passalent^1,2, Christopher Hawke³, Ahmed Omar⁴, Khalid Alnaqbi⁵, Dinny Wallis⁶, Nigil Haroon⁴ and Robert D Inman⁷, ¹Allied Health, Toronto Western Hospital, Toronto, ON, Canada, ²Physical Therapy, University of Toronto, Toronto, ON, Canada, ³Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁴Rheumatology, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada, ⁵Rheumatology, Al Ain Hospital, Al Ain, United Arab Emirates, ⁶University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, ⁷Immunlogy and Institute of Medical Science, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada
Background/Purpose: Emerging models of care in rheumatology are using non-physician health care professionals to assess patients with suspected inflammatory arthritis with the aim to improve…
Abstract Number: 3234 • 2015 ACR/ARHP Annual Meeting
Roadblocks Perceived By Canadian Dermatologists for Referring Patients with Suspected Psoriatic Arthritis
Renise Ayearst¹, Daniel Pereira¹, Charles Lynde², Holly Etchegary³ and Vinod Chandran¹, ¹Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ²University of Toronto, Toronto, ON, Canada, ³Memorial University of Newfoundland, St.John's, NF, Canada
Background/Purpose: The current system of referral by Canadian dermatologists of patients who may have psoriatic arthritis (PsA) to rheumatologists is suboptimal. Hypothesizing that knowledge level,…
Abstract Number: 3235 • 2015 ACR/ARHP Annual Meeting
Factors Associated with Nonadherence to Recently Initiated Disease-Modifying Antirheumatic Drugs
Candace H. Feldman¹, Elena Massarotti², Alyssa Wohlfahrt³, Anarosa Campos³, Yuanyu Lo³, Zhi Zhang³, Maura D. Iversen⁴ and Daniel H. Solomon¹, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ³Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ⁴Northeastern University, Department of Physical Therapy, and Brigham & Women's Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Medication nonadherence accounts for more than $100 billion in preventable healthcare costs annually in the US. Nonadherence to disease-modifying antirheumatic drugs (DMARDs) among patients…
Abstract Number: 3236 • 2015 ACR/ARHP Annual Meeting
Circulating Cytokine/Chemokine Concentrations Predict Cancer Mortality in Men with Rheumatoid Arthritis
Bryant R. England¹, Jeremy Sokolove², William H. Robinson³, Geoffrey M. Thiele⁴, Apar K. Ganti⁵, Harlan Sayles⁶, Kaleb Michaud⁷, Liron Caplan⁸, Lisa A. Davis⁸, Grant W. Cannon⁹, Brian Sauer¹⁰, E. Blair Solow¹¹, Andreas Reimold¹², Gail S. Kerr¹³, Pascale Schwab¹⁴, Joshua F. Baker¹⁵ and Ted R. Mikuls¹⁶, ¹Division of Rheumatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, ²Division of Immunology and Rheumatology, Stanford University Medical Center, Mountain View, CA, ³Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, ⁴Research Services 151, Omaha VA Medical Center, Omaha, NE, ⁵Internal Medicine, Division of Oncology, University of Nebraska Medical Center, Omaha, NE, ⁶University of Nebraska Medical Center, Omaha, NE, ⁷Rheumatology & Immunology, University of Nebraska Medical Center and National Data Base for Rheumatic Diseases, Omaha, NE, ⁸Div of Rheumatology, Univ of CO Denver School of Med, Aurora, CO, ⁹Division of Rheumatology, Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ¹⁰Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, ¹¹Rheumatology, UT Southwestern Medical Center, Dallas, TX, ¹²Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹³VAMC, Georgetown University, Washington, DC, ¹⁴Div Arth & Rheum Dis, Oregon Health & Sci Univ OP09, Portland, OR, ¹⁵Rheumatology, University of Pennsylvania, Philadelphia, PA, ¹⁶Medicine, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Rheumatoid arthritis (RA) is characterized by chronic inflammation and the dysregulated expression of pro-inflammatory cytokines / chemokines (CK). Chronic inflammation has also been implicated…
Abstract Number: 3237 • 2015 ACR/ARHP Annual Meeting
Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?
Elena Myasoedova¹, Cynthia S. Crowson², Eric L. Matteson³, John M. Davis III⁴, Terry M. Therneau⁵ and Sherine E. Gabriel⁶, ¹Internal Medicine and Rheumatology, Mayo Clinic, Rochester, MN, ²Health Sciences Research, Mayo Clinic, Rochester, MN, ³Rheumatology, Mayo Clinic, Rochester, MN, ⁴Division of Rheumatology, Mayo Clinic, Rochester, MN, ⁵Department of Health Sciences Research, Mayo Clinic, Rochester, MN, ⁶Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
Background/Purpose: Rheumatoid arthritis (RA) is associated with increased cardiovascular (CV) morbidity and mortality as compared to the general population. Recent prospective studies with limited follow-up…
Abstract Number: 3238 • 2015 ACR/ARHP Annual Meeting
The Impact of Biologic DMARD Treatment on Sepsis and Mortality after Serious Infection
Adrian Richter¹, Anja Strangfeld², Prof. Dr. Matthias Schneider³, Thomas Klopsch⁴, Andreas Kapelle⁵, Jörg Kaufmann⁶, Angela Zink⁷ and Joachim Listing⁸, ¹German Rheumatism Research Center, Berlin, Germany, ²Epidemiology, German Rheumatism Research Center, Berlin, Germany, ³Rheumatology, Heinrich-Heine-University, Duesseldorf, Germany, ⁴Rheumatologist in private practice, Neubrandenburg, Germany, ⁵Rheumatologist, Hoyerswerda, Germany, ⁶Medical practice specialising, Ludwigsfelde, Germany, ⁷Epidemiologie, Deutsches Rheuma-Forschungszentrum, Berlin, Germany, ⁸Epidemiology, DRFZ, Berlin, Germany
Background/Purpose: Tumor-necrosis-factor-α inhibition (TNFi) was assumed to be a relevant mechanism for the treatment of sepsis[1]. However, randomized controlled trials failed to show a survival…
Abstract Number: 3239 • 2015 ACR/ARHP Annual Meeting
Response to Methotrexate Predicts Mortality in Rheumatoid Arthritis up to 30 Years
Carolin Krause¹, Siegfried Wassenberg², Rolf Rau³, Gertraud Herborn⁴, Juergen Braun⁵ and Dietmar Krause⁶, ¹University Munster, Munster, Germany, ²Rheumaklinik, Themistocles Gluck hospital - Rheumazentrum Ratingen, Ratingen, Germany, ³Expert in Rheumatology, Düsseldorf, Germany, ⁴Evangelisches Fachkrankenhaus Ratingen, Ratingen, Greece, ⁵Rheumazentrum Ruhrgebiet, Herne, Germany, ⁶Dept. for Medical Informatics, Biometry and Epidemiology, Ruhr University, Bochum, Germany
Background/Purpose: Methotrexate (MTX) is considered as the anchor drug for the treatment of patients with rheumatoid arthritis (RA). MTX has been shown to reduce disease…
Abstract Number: 3240 • 2015 ACR/ARHP Annual Meeting
Improved Survival in Rheumatoid Arthritis: A General Population-Based Study
Na Lu^1,2, Hyon K. Choi³, Sara R. Schoenfeld³, Christine Peloquin⁴, Maureen Dubreuil⁵, Sharan K. Rai⁶, J Antonio Avina-Zubieta⁷ and Yuqing Zhang⁸, ¹Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Boston University School of Medicine, Boston, MA, ³Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Rheumatology, Boston VA HealthCare System, Boston, MA, ⁶Experimental Medicine, University of British Columbia, Vancouver, BC, Canada, ⁷Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada, ⁸BUSM, Boston, MA
Background/Purpose: All-cause mortality in UK has been decline by almost 20% over the past two decades. While rheumatoid arthritis (RA) is associated with an increased…
Abstract Number: 3241 • 2015 ACR/ARHP Annual Meeting
Do Boosters Support Long-Term Physical Activity Maintenance after an Intervention? a Systematic Review
Kathryn Remmes Martin¹, Chloé Charlotte Schröder^1,2 and Daniel Whibley¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Faculty For Human and Health Sciences, University of Bremen, Bremen, Germany
Background/Purpose: Physical activity (PA) is an important health behaviour, particularly for individuals with rheumatic and musculoskeletal disease (RMD). While PA interventions can successfully increase PA…
Abstract Number: 3242 • 2015 ACR/ARHP Annual Meeting
A Comprehensive Method for Using Sensewear MiniTM Monitors to Explore Differences in Ambulatory Activities in People Living with and without Early Rheumatoid Arthritis: Moving Beyond Measuring Total Steps
Lynne Feehan^1,2,3, Jake McIvor⁴, Ju Young Yoo³ and Linda Li^3,5, ¹University of British Columbia, Vancouver, BC, Canada, ²Rehabilitation Program, Fraser Health Authority, Surrey, BC, Canada, ³Arthritis Research Canada, Richmond, BC, Canada, ⁴Consultant, Arthritis Research Canada, Richmond, BC, Canada, ⁵Physical Therapy, University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Measures of daily steps does not allow for examination of how steps are accumulated from different type or intensity of ambulatory activity, which is…
Abstract Number: 3243 • 2015 ACR/ARHP Annual Meeting
A Randomized Controlled Trial for a Physical Activity Intervention for RA Fatigue
Patricia P. Katz¹, Mary Margaretten², Steven Gregorich¹, Sandi Kaplan³, Stephanie Rush⁴ and Laura Trupin¹, ¹Medicine, University of California San Francisco, San Francisco, CA, ²Medicine, University of California, San Francisco, San Francisco, CA, ³Arthritis Research Group, University of California, San Francisco, CA, ⁴University of California, San Francisco, San Francisco, CA
Background/Purpose: Fatigue is a major problem for people with RA. Physical inactivity is an indirect risk factor for fatigue1. We tested the effect of a…
Abstract Number: 3244 • 2015 ACR/ARHP Annual Meeting
Evaluation of a Self-Directed Walking Program in Hispanics with Arthritis
Leigh F. Callahan¹, Alfredo Rivadeneira², Mary Altpeter³, Rebecca J. Cleveland⁴, Betsy Hackney¹, Leigha Vilen², Victoria Sepulveda⁴, Daniel S Reuland⁵ and Claudia Rojas⁴, ¹Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ²Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ³Institute on Aging, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁴University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁵Department of Internal Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
Background/Purpose: Walk with Ease (WWE) is the Arthritis Foundation's (AF) 6-week evidence-based walking program for adults with arthritis that can be offered in 2 formats:…
Abstract Number: 3245 • 2015 ACR/ARHP Annual Meeting
Factors Associated with Physical Activity in Older Children with Juvenile Idiopathic Arthritis
Jennifer R. Horonjeff¹, Shira Weiner², Susan Klepper³, Ali Sheikhzadeh², Philip Kahn⁴ and Sherri Weiser², ¹Ergonomics and Biomechanics, New York University, New York, NY, ²Orthopedics, New York University, New York, NY, ³Physical Therapy Program, Columbia University, New York, NY, ⁴Pediatric Rheumatology, New York University, New York, NY
Background/Purpose: The purpose of this study was to examine factors associated with physical activity (PA) in children with JIA. PA is important for the physical,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].